Wird geladen...
CAR T Cell Therapy: Challenges to Bench-to-Bedside Efficacy
Immunotherapy with T cells genetically modified to express chimeric antigen receptors (CARs) that target tumor-associated molecules have impressive efficacy in hematological malignancies. The field has now embraced the challenge of applying this approach to treat common epithelial malignancies, whic...
Gespeichert in:
| Veröffentlicht in: | J Immunol |
|---|---|
| Hauptverfasser: | , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
2018
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5957501/ https://ncbi.nlm.nih.gov/pubmed/29311388 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4049/jimmunol.1701155 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|